These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35192838)

  • 1. Proteasome 26S subunit, non-ATPase 1 (PSMD1) facilitated the progression of lung adenocarcinoma by the de-ubiquitination and stability of PTEN-induced kinase 1 (PINK1).
    Liu L; Liu A; Dong J; Zuo Z; Liu X
    Exp Cell Res; 2022 Apr; 413(2):113075. PubMed ID: 35192838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1.
    Liu L; Liu A; Liu X
    Transl Oncol; 2023 Jan; 27():101586. PubMed ID: 36379103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of proteasome subunit PSMD1 induces cancer cell death via protein ubiquitination and DNA damage, irrespective of p53 status.
    Kim MY; Park ER; Cho EH; Park SH; Han CJ; Kim SB; Gu MB; Shin HJ; Lee KH
    Sci Rep; 2024 Apr; 14(1):7997. PubMed ID: 38580756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSMA5 contributes to progression of lung adenocarcinoma in association with the JAK/STAT pathway.
    Lu F; Zhou J; Chen Q; Zhu J; Zheng X; Fang N; Qiao L
    Carcinogenesis; 2022 Aug; 43(7):624-634. PubMed ID: 35605971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depleting the 19S proteasome regulatory PSMD1 subunit as a cancer therapy strategy.
    Adler J; Oren R; Shaul Y
    Cancer Med; 2023 May; 12(9):10781-10790. PubMed ID: 36934426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.
    Rubio AJ; Bencomo-Alvarez AE; Young JE; Velazquez VV; Lara JJ; Gonzalez MA; Eiring AM
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Silence of PSMC6 Inhibits Cell Growth and Metastasis in Lung Adenocarcinoma.
    Zhang JY; Shi KZ; Liao XY; Li SJ; Bao D; Qian Y; Li DJ
    Biomed Res Int; 2021; 2021():9922185. PubMed ID: 34239933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA-LINC01089 inhibits lung adenocarcinoma cell proliferation and promotes apoptosis via sponging miR-543.
    Xu Y; Lin L; Lv D; Yan S; He S; Ge H
    Tissue Cell; 2021 Oct; 72():101535. PubMed ID: 33892399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
    Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
    Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
    [No Abstract]   [Full Text] [Related]  

  • 11. TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG.
    Wang J; Pan X; Li J; Zhao J
    Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35485284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
    Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
    Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
    [No Abstract]   [Full Text] [Related]  

  • 13. LncRNA LINC00680 promotes lung adenocarcinoma growth via binding to GATA6 and canceling GATA6-mediated suppression of SOX12 expression.
    Sun X; Wang R; Tan M; Tian X; Meng J
    Exp Cell Res; 2021 Aug; 405(1):112653. PubMed ID: 34029572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome 26S subunit PSMD1 regulates breast cancer cell growth through p53 protein degradation.
    Okumura T; Ikeda K; Ujihira T; Okamoto K; Horie-Inoue K; Takeda S; Inoue S
    J Biochem; 2018 Jan; 163(1):19-29. PubMed ID: 28992264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
    Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
    J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1.
    Wang M; Liao Q; Zou P
    Cancer Biol Ther; 2020 Apr; 21(4):364-371. PubMed ID: 31939714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PINK1-induced phosphorylation of mitofusin 2 at serine 442 causes its proteasomal degradation and promotes cell proliferation in lung cancer and pulmonary arterial hypertension.
    Dasgupta A; Chen KH; Lima PDA; Mewburn J; Wu D; Al-Qazazi R; Jones O; Tian L; Potus F; Bonnet S; Archer SL
    FASEB J; 2021 Aug; 35(8):e21771. PubMed ID: 34275172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma.
    Wei S; Xing J; Chen J; Chen L; Lv J; Chen X; Li T; Yu T; Wang H; Wang K; Yu W
    J Exp Clin Cancer Res; 2024 Jan; 43(1):3. PubMed ID: 38163876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.